Full text

Turn on search term navigation

© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Background

The prevalence and mortality of bladder cancer (BLCA) present a significant medical challenge. While the function of senescence-related genes in tumor development is recognized, their prognostic significance in BLCA has not been thoroughly explored.

Methods

BLCA transcriptome datasets were sourced from the TCGA and GEO repositories. Gene groupings were determined through differential gene expression and non-negative matrix factorization (NMF) methodologies. Key senescence-linked genes were isolated using singular and multivariate Cox regression analyses, combined with lasso regression. Validation was undertaken with GEO database information. Predictive models, or nomograms, were developed by merging risk metrics with clinical records, and their efficacy was gauged using ROC curve methodologies. The immune response’s dependency on the risk metric was assessed through the immune phenomenon score (IPS). Additionally, we estimated IC50 metrics for potential chemotherapeutic agents.

Results

Reviewing 406 neoplastic and 19 standard tissue specimens from the TCGA repository facilitated the bifurcation of subjects into two unique clusters (C1 and C2) according to senescence-related gene expression. After a stringent statistical evaluation, a set of ten pivotal genes was discerned and applied for risk stratification. Validity tests for the devised nomograms in forecasting 1, 3, and 5-year survival probabilities for BLCA patients were executed via ROC and calibration plots. IC50 estimations highlighted a heightened responsiveness in the low-risk category to agents like cisplatin, cyclopamine, and sorafenib.

Conclusions

In summation, our research emphasizes the prospective utility of risk assessments rooted in senescence-related gene signatures for enhancing BLCA clinical oversight.

Details

Title
Comprehensive analysis and prognostic assessment of senescence-associated genes in bladder cancer
Author
Yang, Ruilin 1 ; He, Jieling 2 ; Luo, Wenfeng 3 ; Xiang, Renyang 4 ; Zou, Ge 5 ; Zhang, Xintao 6 ; Liu, Huang 7 ; Deng, Junhong 8 

 Jinan University, Guangzhou, China (GRID:grid.258164.c) (ISNI:0000 0004 1790 3548); The Affiliated Panyu Central Hospital of Guangzhou Medical University, Andrology Clinic, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072) 
 The Affiliated Panyu Central Hospital of Guangzhou Medical University, Ultrasonography Department, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072) 
 The Affiliated Panyu Central Hospital of Guangzhou Medical University, Central Laboratory, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072) 
 The University of HongKong-Shenzhen Hospital, Department of Surgery, Shenzhen, China (GRID:grid.440671.0) (ISNI:0000 0004 5373 5131) 
 The Affiliated Panyu Central Hospital of Guangzhou Medical University, Urology Department, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072) 
 The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Department of Urology, Shenzhen, China (GRID:grid.452847.8) (ISNI:0000 0004 6068 028X) 
 Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), Human Sperm Bank of Guangdong Province, National Health Commission (NHC) Key Laboratory of Male Reproduction and Genetics, Department of Andrology, Guangzhou, China (GRID:grid.452847.8) 
 The Second Affiliated Hospital of South China University of Technology, Department of Andrology, Guangzhou First People’s Hospital, Guangzhou, China (GRID:grid.413432.3) (ISNI:0000 0004 1798 5993) 
Pages
130
Publication year
2024
Publication date
Dec 2024
Publisher
Springer Nature B.V.
e-ISSN
27306011
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3046998797
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.